LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $169,000 | -43.1% | 22,891 | -46.7% | 0.00% | – |
| Q4 2016 | $297,000 | -15.1% | 42,914 | +0.5% | 0.00% | – |
| Q3 2016 | $350,000 | +45.8% | 42,694 | +42.9% | 0.00% | – |
| Q2 2016 | $240,000 | +605.9% | 29,883 | +336.6% | 0.00% | – |
| Q1 2016 | $34,000 | -78.2% | 6,844 | -66.5% | 0.00% | – |
| Q4 2015 | $156,000 | +26.8% | 20,413 | -6.1% | 0.00% | – |
| Q3 2015 | $123,000 | -32.8% | 21,740 | +8.6% | 0.00% | – |
| Q2 2015 | $183,000 | -34.2% | 20,020 | -13.0% | 0.00% | – |
| Q1 2015 | $278,000 | – | 23,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
| ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
| P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
| Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
| NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
| Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
| Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
| QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
| Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |